Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The treatment was effective for advanced non-Hodgkin's lymphomas.